January 28, 2013
Gilead Sciences to Release Fourth Quarter and Year End 2012 Financial Results on Monday, February 4, 2013
Conference Call and Webcast to Follow
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 28, 2013--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth
quarter and year end 2012 financial results will be released on Monday,
February 4, at 4:05 p.m. Eastern Time. At 4:30 p.m. Eastern Time,
Gilead’s management will host a conference call to discuss the company’s
financial results for the fourth quarter and full year 2012 and provide
a general business update and financial guidance for 2013. The
conference call will be accessible via the internet from the company’s
To access the webcast link, log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-800-901-5231 (U.S.) or 1-617-786-2961 (international) and dial the
participant passcode 49057415 to access the call. Telephone replay will
be available approximately two hours after the call through 11:59 p.m.
Eastern Time, February 7, 2013. To access the replay, please call
1-888-286-8010 (U.S.) or 1-617-801-6888 (international) and dial the
participant passcode 15606712. The webcast will be archived on www.gilead.com
for one year.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Asia
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936 (Investor